GP29 T24099
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
GP29 is a Type II kinase inhibitor of the IRE1_ endoribonuclease that acts by targeting the ATP-binding pocket of IRE1_.
CAS nr:
1415050-59-7
Purity:
98%
Molecular Weight:
599,61
SMILES:
O=C(NC1=CC=C(C)C(C2=CC3=CN=C(NC4=CC=C(OCCNC(C)=O)C=C4)N=C3C=C2)=C1)C5=CC=CC(C(F)(F)F)=C5
Formula:
C33H28F3N5O3
Pathway:
Target:



